These micro-recoveries add up and support both weight loss and emotional wellbeing
A large meta-analysis of 64 trials with over 25,500 adults with type 2 diabetes showed that GLP-1s were more effective at reducing A1C levels compared to placebo and traditional diabetes drugs
In a mouse model of hepatocellular carcinoma induced by diethylnitrosamine (DEN), liver GCN5L1 knockout increased DEN sensitivity in the model
Purchasing these compounds from unregulated online sources often labelled as 'research chemicals' or 'not for human use' does not circumvent legal or safety obligations
JAMA 303:14101418 Pratley RE, Nauck M, Bailey T et al (2010) Liraglutide vs sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
GLP-1RAs appear to offer a potential dual therapeutic advantage, simultaneously targeting metabolic dysfunction and immune-mediated inflammation, thereby representing a potentially promising strategy in the management of early-stage PsA early PsA, although robust clinical evidence in this setting is currently lacking